Bracelet maker accused of false claims

Aug 23, 2006

The manufacturer of the "ionized" Q-Ray bracelet has been accused in Chicago of false advertising for claiming the product acts as a pain reliever.

A Chicago judge is expected to decide this week whether infomercial entrepreneur Andrew Park and his company must pay $87 million and cease claims about the bracelets pain-relieving effects, the Chicago Tribune reported Wednesday.

A Mayo Clinic study published in 2002 found the bracelets did not actually relieve pain, but gave some wearers a placebo effect, which causes patients to feel better because they expect to.

However, attorneys for Park's QT Inc. claim the cause of the relief doesn't matter, so long as it occurs.

"More than three out of four people got relief from this product," said Michael Ficaro, attorney for QT Inc. "And the other quarter who didn't got their money back ... How in the world does that violate the (false advertising) act?"

The Federal Trade Commission, which brought the suit against QT, has obtained a temporary court order stopping the company from making pain relief claims while the trial is ongoing.

Copyright 2006 by United Press International

Explore further: Bacteria blamed in indigenous Mexican baby deaths

Related Stories

EEG helmet is being developed as interrogation device

Jul 12, 2012

(Phys.org) -- Veritas Scientific is working on an EEG helmet that carries a slideshow of images that could, they hope, reliably identify an enemy. The device is shaped like a motorcycle-helmet with metal brush ...

Recommended for you

Bacteria blamed in indigenous Mexican baby deaths

21 hours ago

Bacteria—and not a contaminated vaccine as initially suspected—were to blame for the recent deaths of two Mexican babies and for sickening 29 others, according to an official investigation.

German woman, 65, gives birth to quadruplets

21 hours ago

A 65-year-old teacher from Berlin has given birth to quadruplets after a pregnancy that was widely criticized by medical professionals because of her age, RTL television said Saturday.

US appeals court upholds delay in Alzheimer's drug swap

May 22, 2015

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.